J. P. Gagnol

493 total citations
22 papers, 394 citations indexed

About

J. P. Gagnol is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Surgery. According to data from OpenAlex, J. P. Gagnol has authored 22 papers receiving a total of 394 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Cardiology and Cardiovascular Medicine, 8 papers in Molecular Biology and 6 papers in Surgery. Recurrent topics in J. P. Gagnol's work include Cardiac electrophysiology and arrhythmias (9 papers), Anesthesia and Sedative Agents (4 papers) and Heart Rate Variability and Autonomic Control (4 papers). J. P. Gagnol is often cited by papers focused on Cardiac electrophysiology and arrhythmias (9 papers), Anesthesia and Sedative Agents (4 papers) and Heart Rate Variability and Autonomic Control (4 papers). J. P. Gagnol collaborates with scholars based in France, Italy and United States. J. P. Gagnol's co-authors include Patrick Gautier, Emanuela Masini, A Sassine, J.J. Eledjam, Josép Brugada, George E. Billman, Peter J. Schwartz, H. L. Stone, M. Clinet and Pierre Petit and has published in prestigious journals such as Biochemistry, Journal of Applied Physiology and Journal of Medicinal Chemistry.

In The Last Decade

J. P. Gagnol

20 papers receiving 371 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J. P. Gagnol France 12 145 144 116 57 53 22 394
K. Nakamura Japan 9 65 0.4× 70 0.5× 72 0.6× 66 1.2× 46 0.9× 22 387
Patrick E. Benedict United States 7 63 0.4× 77 0.5× 44 0.4× 86 1.5× 40 0.8× 10 341
Stanley Leeson United States 11 55 0.4× 178 1.2× 65 0.6× 66 1.2× 42 0.8× 15 345
Louis Dumont Canada 11 151 1.0× 119 0.8× 150 1.3× 7 0.1× 104 2.0× 50 489
Michael N. Hartnett United States 7 38 0.3× 53 0.4× 114 1.0× 17 0.3× 32 0.6× 9 453
K. Frislid Norway 14 56 0.4× 216 1.5× 96 0.8× 10 0.2× 13 0.2× 22 516
J Scholtholt Germany 12 113 0.8× 80 0.6× 48 0.4× 7 0.1× 33 0.6× 33 320
P.J.D. Snow United Kingdom 10 244 1.7× 73 0.5× 57 0.5× 10 0.2× 32 0.6× 20 568
M F Rack United States 13 139 1.0× 388 2.7× 51 0.4× 22 0.4× 21 0.4× 15 816
G Deltour France 12 172 1.2× 18 0.1× 129 1.1× 13 0.2× 37 0.7× 64 459

Countries citing papers authored by J. P. Gagnol

Since Specialization
Citations

This map shows the geographic impact of J. P. Gagnol's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. P. Gagnol with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. P. Gagnol more than expected).

Fields of papers citing papers by J. P. Gagnol

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. P. Gagnol. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. P. Gagnol. The network helps show where J. P. Gagnol may publish in the future.

Co-authorship network of co-authors of J. P. Gagnol

This figure shows the co-authorship network connecting the top 25 collaborators of J. P. Gagnol. A scholar is included among the top collaborators of J. P. Gagnol based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. P. Gagnol. J. P. Gagnol is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gueyffier, François, Fabien Subtil, Théodora Bejan‐Angoulvant, et al.. (2014). Can we identify response markers to antihypertensive drugs? First results from the IDEAL Trial. Journal of Human Hypertension. 29(1). 22–27. 13 indexed citations
2.
Galtier, Florence, Thibault Mura, Éric Raynaud de Mauverger, et al.. (2012). Effect of a high dose of simvastatin on muscle mitochondrial metabolism and calcium signaling in healthy volunteers. Toxicology and Applied Pharmacology. 263(3). 281–286. 39 indexed citations
3.
Giudice, Pietro, J. P. Gagnol, Alessandro Bellucci, et al.. (2000). Autonomic Nervous System Activity Imbalance in Cardiomyopathic Hamster. Journal of Cardiovascular Pharmacology. 36(3). 369–375. 11 indexed citations
4.
Coussaye, J.-E. de La, Jean‐Jacques Eledjam, Pascale Fabbro-Péray, et al.. (1993). LEMAKALIM, A POTASSIUM CHANNEL AGONIST, REVERSES ELECTROPHYSIOLOGICAL IMPAIRMENTS INDUCED BY A LARGE DOSE OF BUPIVACAINE IN ANAESTHETIZED DOGS. British Journal of Anaesthesia. 71(4). 534–539. 14 indexed citations
5.
Coussaye, J.-E. de La, P Bruelle, J. P. Gagnol, et al.. (1992). Reduction by carbachol of ventricular conduction impairments induced by various class I antiarrhythmic drugs in anesthetized dogs.. PubMed. 315. 47–62. 1 indexed citations
6.
Gagnol, J. P., et al.. (1992). Experimental Evidence in Favor of Role of Intracellular Actions of Bupivacaine in Myocardial Depression. Anesthesia & Analgesia. 74(5). 698???702–698???702. 18 indexed citations
7.
Brugada, Josép, et al.. (1992). Reversal of Electrophysiologic and Hemodynamic Effects Induced by High Dose of Bupivacaine by the Combination of Clonidine and Dobutamine in Anesthetized Dogs. Anesthesia & Analgesia. 74(5). 703???711–703???711. 22 indexed citations
8.
Coussaye, J.-E. de La, J.J. Eledjam, Josép Brugada, et al.. (1990). Les bêta-bloquants aggravent-ils la cardiotoxicité de la bupivacaïne ?. Annales Françaises d Anesthésie et de Réanimation. 9(2). 132–136. 5 indexed citations
9.
Eledjam, J.J., et al.. (1989). In Vitro Study on Mechanisms of Bupivacaine-Induced Depression of Myocardial Contractility. Anesthesia & Analgesia. 69(6). 732???735–732???735. 62 indexed citations
10.
Galindo, G, et al.. (1987). Hemodynamic Response to SR 42128A in Normal and Sodium-Depleted Baboons. Journal of Cardiovascular Pharmacology. 10. 99–101. 4 indexed citations
11.
Cumin, Frédéric, Dino Nisato, J. P. Gagnol, & Pierre Corvol. (1987). A potent radiolabeled human renin inhibitor [3H]SR42128: enzymatic, kinetic, and binding studies to renin and other aspartic proteases. Biochemistry. 26(24). 7615–7621. 2 indexed citations
12.
Billman, George E., Peter J. Schwartz, J. P. Gagnol, & H. L. Stone. (1985). Cardiac response to submaximal exercise in dogs susceptible to sudden cardiac death. Journal of Applied Physiology. 59(3). 890–897. 31 indexed citations
13.
Gagnol, J. P., et al.. (1985). Amiodarone*. Drugs. 29(Supplement 3). 1–10. 22 indexed citations
14.
Cazaubon, Catherine, C Lacour, Dino Nisato, et al.. (1985). In Vitro and In Vivo Inhibition of Human and Primate Renin by a New Potent Renin Inhibitor. Journal of Cardiovascular Pharmacology. 7. S58–S61. 9 indexed citations
15.
Gagnol, J. P., et al.. (1985). Histamine release during an experimental coronary thrombosis in awake dog. Inflammation Research. 16(3-4). 227–230. 27 indexed citations
16.
Masini, Emanuela, et al.. (1985). Histamine-releasing properties of Polysorbate 80in vitro andin vivo: correlation with its hypotensive action in the dog. Inflammation Research. 16(6). 470–477. 88 indexed citations
17.
Schwartz, Peter J., George E. Billman, J. P. Gagnol, & H. L. Stone. (1984). Vagal reflexes elicited by acute myocardial ischemia during exercise in dogs with a healed myocardial infarction. Federation Proceedings. 43(3).
18.
Gagnol, J. P., Peter J. Schwartz, George E. Billman, & H. L. Stone. (1983). Hemodynamic response to exercise following oral administration of amiodarone. Federation Proceedings. 42(5).
19.
Roncucci, R., et al.. (1983). Synthesis and antiarrhythmic activity of new [(dialkylamino)alkyl]pyridylacetamides. Journal of Medicinal Chemistry. 26(3). 451–455. 17 indexed citations
20.
Selam, J. L., et al.. (1981). Effects of somatostatin added to insulin in a glucose-controlled insulin infusion system. Diabetologia. 21(2). 126–30. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by K. Nakamura Breakdown of academic impact, for papers by Patrick E. Benedict Breakdown of academic impact, for papers by Stanley Leeson Breakdown of academic impact, for papers by Louis Dumont Breakdown of academic impact, for papers by Michael N. Hartnett Breakdown of academic impact, for papers by K. Frislid Breakdown of academic impact, for papers by J Scholtholt Breakdown of academic impact, for papers by P.J.D. Snow Breakdown of academic impact, for papers by M F Rack Breakdown of academic impact, for papers by G Deltour
Rankless by CCL
2026